The cognitive and neural effects of the APOE gene have been subject to intense study in recent years, on the basis that carriers of the ε4 variant are at considerably higher risk of developing late onset Alzheimer’s disease (AD) [2] and also show poorer cognitive ageing in non-clinical populations [13]. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.